Literature DB >> 16252025

Renal cell carcinoma: diagnosis and treatment, 1994-2003.

Thomas E Hutson1.   

Abstract

Entities:  

Year:  2005        PMID： 16252025      PMCID： PMC1255944          DOI： 10.1080/08998280.2005.11928093

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  31 in total

Review 1.  Immunotherapy for renal cell cancer.

Authors:  M Bower; R Roylance; J Waxman
Journal:  QJM       Date:  1998-09

2.  Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Authors:  S Störkel; J N Eble; K Adlakha; M Amin; M L Blute; D G Bostwick; M Darson; B Delahunt; K Iczkowski
Journal:  Cancer       Date:  1997-09-01       Impact factor: 6.860

3.  TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Authors:  P Guinan; L H Sobin; F Algaba; F Badellino; S Kameyama; G MacLennan; A Novick
Journal:  Cancer       Date:  1997-09-01       Impact factor: 6.860

Review 4.  Systemic therapy for renal cell carcinoma.

Authors:  R J Motzer; P Russo
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

5.  Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.

Authors:  S Negrier; B Escudier; C Lasset; J Y Douillard; J Savary; C Chevreau; A Ravaud; A Mercatello; J Peny; M Mousseau; T Philip; T Tursz
Journal:  N Engl J Med       Date:  1998-04-30       Impact factor: 91.245

6.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

7.  Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

8.  Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control.

Authors:  H Van Poppel; B Bamelis; R Oyen; L Baert
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

9.  Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy.

Authors:  J A Saidi; J H Newhouse; I S Sawczuk
Journal:  Urology       Date:  1998-12       Impact factor: 2.649

10.  Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial.

Authors:  F Boccardo; A Rubagotti; L Canobbio; E Galligioni; R Sorio; A Lucenti; F Cognetti; E Ruggeri; G Landonio; C Baiocchi; C Besana; G Citterio; M De Rosa; F Calabresi
Journal:  Tumori       Date:  1998 Sep-Oct
View more
  5 in total

1.  Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma.

Authors:  Maria Helena Bellini; Enia Lúcia Coutinho; Lilia Coronato Courrol; Flávia Rodrigues de Oliveira Silva; Nilson Dias Vieira Júnior; Nestor Schor
Journal:  J Fluoresc       Date:  2008-05-17       Impact factor: 2.217

Review 2.  Current management and future directions in the treatment of advanced renal cell carcinoma-a latin american perspective: 10 years in review.

Authors:  Oren Smaletz
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

3.  Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach.

Authors:  Filipa Amaro; Joana Pinto; Sílvia Rocha; Ana Margarida Araújo; Vera Miranda-Gonçalves; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolites       Date:  2020-04-27

4.  Effects of Curcumin Analogues DMC and EF24 in Combination with the Cytokine TRAIL against Kidney Cancer.

Authors:  Verónica Ibáñez Gaspar; Jasmin McCaul; Hilary Cassidy; Craig Slattery; Tara McMorrow
Journal:  Molecules       Date:  2021-10-18       Impact factor: 4.411

5.  Curcumin Sensitises Cancerous Kidney Cells to TRAIL Induced Apoptosis via Let-7C Mediated Deregulation of Cell Cycle Proteins and Cellular Metabolism.

Authors:  Ismael Obaidi; Alfonso Blanco Fernández; Tara McMorrow
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.